Literature DB >> 12058027

Mechanism of activation of protein kinase D2(PKD2) by the CCK(B)/gastrin receptor.

Sabine Sturany1, Johan Van Lint, Annette Gilchrist, Jackie R Vandenheede, Guido Adler, Thomas Seufferlein.   

Abstract

Recently, we cloned a novel serine/threonine kinase termed protein kinase D2 (PKD2). PKD2 can be activated by phorbol esters both in vivo and in vitro but also by gastrin via the cholecystokinin/CCK(B) receptor in human gastric cancer cells stably transfected with the CCK(B)/gastrin receptor (AGS-B cells). Here we identify the mechanisms of gastrin-induced PKD2 activation in AGS-B cells. PKD2 phosphorylation in response to gastrin was rapid, reaching a maximum after 10 min of incubation. Our data demonstrate that gastrin-stimulated PKD2 activation involves a heterotrimeric G alpha(q) protein as well as the activation of phospholipase C. Furthermore, we show that PKD2 can be activated by classical and novel members of the protein kinase C (PKC) family such as PKC alpha, PKC epsilon, and PKC eta. These PKCs are activated by gastrin in AGS-B cells. Thus, PKD2 is likely to be a novel downstream target of specific PKCs upon the stimulation of AGS-B cells with gastrin. Our data suggest a two-step mechanism of activation of PKD2 via endogenously produced diacylglycerol and the activation of PKCs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12058027     DOI: 10.1074/jbc.M200934200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.

Authors:  Ninel Azoitei; Alexander Kleger; Nina Schoo; Dietmar Rudolf Thal; Cornelia Brunner; Ganesh Varma Pusapati; Alina Filatova; Felicitas Genze; Peter Möller; Til Acker; Rainer Kuefer; Johan Van Lint; Heinrich Baust; Guido Adler; Thomas Seufferlein
Journal:  Neuro Oncol       Date:  2011-07       Impact factor: 12.300

2.  Overexpression of wild-type PKD2 leads to increased proliferation and invasion of BON endocrine cells.

Authors:  Lindsey N Jackson; Jing Li; L Andy Chen; Courtney M Townsend; B Mark Evers
Journal:  Biochem Biophys Res Commun       Date:  2006-07-31       Impact factor: 3.575

Review 3.  Protein kinase D2: a versatile player in cancer biology.

Authors:  Ninel Azoitei; Mathias Cobbaut; Alexander Becher; Johan Van Lint; Thomas Seufferlein
Journal:  Oncogene       Date:  2017-12-20       Impact factor: 9.867

4.  Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.

Authors:  Hui Zheng; Juan Qian; Bentley Varghese; Darren P Baker; Serge Fuchs
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

5.  Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling.

Authors:  Alexandra Auer; Julia von Blume; Sabine Sturany; Götz von Wichert; Johan Van Lint; Jackie Vandenheede; Guido Adler; Thomas Seufferlein
Journal:  Mol Biol Cell       Date:  2005-06-22       Impact factor: 4.138

6.  Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells.

Authors:  Sharon A Matthews; Maria N Navarro; Linda V Sinclair; Elizabeth Emslie; Carmen Feijoo-Carnero; Doreen A Cantrell
Journal:  Biochem J       Date:  2010-11-15       Impact factor: 3.857

7.  Protein kinase D isozymes activation and localization during mitosis.

Authors:  Romeo Papazyan; Michael Doche; Richard T Waldron; Enrique Rozengurt; Mary Pat Moyer; Osvaldo Rey
Journal:  Exp Cell Res       Date:  2008-07-26       Impact factor: 3.905

8.  Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2.

Authors:  J von Blume; Uwe Knippschild; Franck Dequiedt; Georgios Giamas; Alexander Beck; Alexandra Auer; Johan Van Lint; Guido Adler; Thomas Seufferlein
Journal:  EMBO J       Date:  2007-10-25       Impact factor: 11.598

9.  In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts.

Authors:  Jianxia Guo; Dana M Clausen; Jan H Beumer; Robert A Parise; Merrill J Egorin; Karla Bravo-Altamirano; Peter Wipf; Elizabeth R Sharlow; Qiming Jane Wang; Julie L Eiseman
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-30       Impact factor: 3.333

Review 10.  Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.

Authors:  Serge Y Fuchs
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.